| 000 | 01529 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517084734.0 | ||
| 264 | 0 | _c20180703 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155216638551 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCooper, Jalyn | |
| 245 | 0 | 0 |
_aAcute encephalopathy with combination dabrafenib/trametinib therapy. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cJun 2017 |
||
| 300 |
_a313-317 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBrain Diseases _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aOximes _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyridones _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidinones _xadministration & dosage |
| 700 | 1 | _aKodali, Dheeraj | |
| 700 | 1 | _aHiga, Gerald M | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 23 _gno. 4 _gp. 313-317 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155216638551 _zAvailable from publisher's website |
| 999 |
_c25838291 _d25838291 |
||